TITLE:
Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection

CONDITION:
Bacterial Infections

INTERVENTION:
Piperacillin/Tazobactam

SUMMARY:

      A Phase IV, multicenter study of hospitalized patients with complicated intra-abdominal
      infection.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

          -  Written informed consent will be obtained prior to enrollment into the study. If any
             patient is unable to give consent, it may be obtained from next of-kin or a legal
             representative if in accordance with local laws and regulations

          -  Hospitalized, 18 years of age

          -  Male or non-pregnant, non-lactating female who is post-menopausal, surgically
             sterilized or is using birth control pills, contraceptive implant or injection (ex:
             NORPLANT; DEPO-PROVERA), intra-uterine device, barrier methods with spermicide, or
             abstinence. (Effective contraception should have been in place for at least two
             months prior to study entry and must continue for at least 30 days after treatment
             discontinuation)

        Exclusion Criteria

          -  Patients with underlying immunodeficiency disease or patients requiring chronic
             treatment with known immunosuppressant medications including >5mg/day prednisone

          -  Active or treated leukemia, or systemic malignancy that required treatment with
             chemotherapy, immunotherapy, radiation therapy, or antineoplastic therapy within the
             past year or which is anticipated to begin prior to the Test-of-Cure visit; or any
             known or suspected malignancy to the abdomen

          -  Concurrent hemodialysis, peritoneal dialysis or patients with indwelling peritoneal
             catheters or shunts, plasmapheresis or hemoperfusion
      
